Cost-effectiveness analysis of the treatment of mild and moderate Alzheimer’s disease in Brazil

OBJECTIVE: To perform a cost-effectiveness analysis of donepezil and rivastigmine therapy for mild and moderate Alzheimer’s disease (AD) from the perspective of the Brazilian Unified Health System. METHOD: A hypothetical cohort of 1,000 individuals of both sexes, aged >65 years, and diagnosed wit...

Descripción completa

Detalles Bibliográficos
Autores principales: da Silva, Luciana R., Vianna, Cid M.M., Mosegui, Gabriela B.G., Peregrino, Antônio A.F., Marinho, Valeska, Laks, Jerson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Psiquiatria 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794128/
https://www.ncbi.nlm.nih.gov/pubmed/30427385
http://dx.doi.org/10.1590/1516-4446-2017-0021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794128/
https://www.ncbi.nlm.nih.gov/pubmed/30427385
http://dx.doi.org/10.1590/1516-4446-2017-0021

Ejemplares similares